Compare Danaher Corporation (DHR) vs Raymond James Financial, Inc. (RJF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Raymond James Financial, Inc. — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Raymond James Financial, Inc. trades at $158.28 (market cap $30.51B). The key difference: Danaher Corporation is far larger — about 5× Raymond James Financial, Inc.'s market cap, and Raymond James Financial, Inc. pays the higher dividend (1.36%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Raymond James Financial, Inc. for 75 Days on average.
| DHR | RJF | |
|---|---|---|
Market Cap | $152.87B | $30.51B |
Volume | 5,228,698 | 1,206,253 |
Sector | Health | Financials |
52-Week High | $242.05 | $181.18 |
52-Week Low | $161.91 | $140.89 |
Typical Hold Time | 69 Days | 75 Days |
Enterprise Value | $175.08B | $24.37B |
Dividend Yield | 0.74% | 1.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
Raymond James Financial (RJF) trades at $158.6, up 0.83% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company has delivered three consecutive quarterly earnings beats, with Q3 2026 EPS of $3.14 exceeding the $2.93 estimate. Revenue growth has been steady, rising from $10.9B in 2022 to $13.84B in 2025, supported by a robust net income margin of 15.37% and an ROE of 18.48%.
The outlook is balanced: analyst consensus is a 'Hold' with a $184 price target, implying 16% upside, but technical weakness and volatile cash flows from aggressive investing activities pose near-term risks. Long-term growth drivers include wealth management expansion and investment banking recovery, though rising expenses and market volatility remain headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →
